Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IDEX Biometrics ASAOSL:IDEX +2.13%32 Cyclically Adjusted PS Ratio is 1.04 as of Aug. 24, 2026, which is 99% below its 10-year median of 81.84. GuruFocus rates OSL:IDEX with a GF Score™ of 32/100 and a GF Value™ of kr0.51 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 1,591 Software companies, IDEX Biometrics ASA ranks better than 63.42% on this metric.
The historical rank and industry rank for IDEX Biometrics ASA's Cyclically Adjusted PS Ratio or its related term are showing as below:
OSL:IDEX'
s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.33 Med: 81.84 Max: 448.54
Current: 1.04
During the past years, IDEX Biometrics ASA's highest Cyclically Adjusted PS Ratio was 448.54. The lowest was 0.33. And the median was 81.84.
OSL:IDEX's Cyclically Adjusted PS Ratio is ranked better than 63.42% of 1591
companies
in the Software industry
Industry Median: 1.67
vs OSL:IDEX: 1.04
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
IDEX Biometrics ASA's adjusted revenue per share data for the three months ended in Jun. 2026 was kr0.023. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is kr7.39 for the trailing ten years ended in Jun. 2026.
Shiller PE for Stocks: The True Measure of Stock Valuation
IDEX Biometrics ASA (OSL:IDEX) Cyclically Adjusted PS Ratio Explanation
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
IDEX Biometrics ASA Cyclically Adjusted PS Ratio Related Terms
IDEX Biometrics ASA Cyclically Adjusted PS Ratio Historical Data
* Premium members only.
The historical data trend for IDEX Biometrics ASA's Cyclically Adjusted PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IDEX Biometrics ASA Cyclically Adjusted PS Ratio Chart
OSL:IDEX vs QH, SHOP, UBER: Cyclically Adjusted PS Ratio Comparison
For the Software - Application subindustry, IDEX Biometrics ASA's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IDEX Biometrics ASA Cyclically Adjusted PS Ratio vs Software Industry
For the Software industry and Technology sector, IDEX Biometrics ASA's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where IDEX Biometrics ASA's Cyclically Adjusted PS Ratio falls into.
IDEX Biometrics ASA Cyclically Adjusted PS Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
IDEX Biometrics ASA's Cyclically Adjusted PS Ratio for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PS Ratio of 1.04 mean?
IDEX Biometrics ASA (OSL:IDEX) has a Cyclically Adjusted PS Ratio of 1.04 as of Aug. 24, 2026. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on IDEX Biometrics ASA and its competitors. This is 99% below median its historical median of 81.84. Over the past decade, IDEX Biometrics ASA's Cyclically Adjusted PS Ratio has ranged from 0.33 to 448.54. According to the industry distribution chart, IDEX Biometrics ASA ranks #582 out of 1591 companies in the Software industry, placing it in the top 36.6%.
Is IDEX Biometrics ASA's Cyclically Adjusted PS Ratio too high?
IDEX Biometrics ASA's current Cyclically Adjusted PS Ratio of 1.04 is 99% below median its 10-year median of 81.84. Over the past 10 years, this metric has ranged from a low of 0.33 to a high of 448.54. The Software industry median Cyclically Adjusted PS Ratio is 1.67. IDEX Biometrics ASA's value of 1.04 is 37.7% below this industry median. Based on the distribution chart, IDEX Biometrics ASA ranks #582 out of 1591 companies in the Software industry, which is above the industry midpoint. Overall, IDEX Biometrics ASA has a GF Score™ of 32/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IDEX Biometrics ASA's Cyclically Adjusted PS Ratio compare to QH and SHOP?
According to the Software industry distribution chart, IDEX Biometrics ASA ranks #582 out of 1591 companies for Cyclically Adjusted PS Ratio. This puts IDEX Biometrics ASA in the upper half of its industry. The industry median Cyclically Adjusted PS Ratio is 1.67. IDEX Biometrics ASA's value of 1.04 is 37.7% below this benchmark. Historically, IDEX Biometrics ASA's own Cyclically Adjusted PS Ratio has ranged from 0.33 to 448.54 over the past decade. While the company's 10-year median is 81.84 vs. the industry median of 1.67, IDEX Biometrics ASA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PS Ratio for a Software company?
The median Cyclically Adjusted PS Ratio among Software companies is 1.67, based on 1,591 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IDEX Biometrics ASA's current Cyclically Adjusted PS Ratio of 1.04 is 37.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PS Ratio mean?
A high Cyclically Adjusted PS Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on IDEX Biometrics ASA and its competitors. For the Software industry, the median Cyclically Adjusted PS Ratio is 1.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IDEX Biometrics ASA's current Cyclically Adjusted PS Ratio is 1.04, which is 99% below median its own 10-year median of 81.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDEX Biometrics ASA stock overvalued right now?
Based on GuruFocus' analysis, IDEX Biometrics ASA (OSL:IDEX) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.51, compared to a current price of kr7.66 — trading 1402% above its estimated fair value. The current Cyclically Adjusted PS Ratio is 1.04, which is 99% below median its 10-year median of 81.84 and 37.7% below the Software industry median of 1.67. IDEX Biometrics ASA's overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PS Ratio calculated?
Cyclically Adjusted PS Ratio is calculated from a company's financial statements. For IDEX Biometrics ASA (OSL:IDEX), the current Cyclically Adjusted PS Ratio is 1.04 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IDEX Biometrics ASA (OSL:IDEX) Overvalued in 2026?
Based on GuruFocus' analysis, IDEX Biometrics ASA stock appears to be overvalued.
The current stock price of kr7.66 is trading 1402% above its estimated GF Value™ of kr0.51.
GuruFocus considers IDEX Biometrics ASA to be Significantly Overvalued.
Key valuation signals for OSL:IDEX:
Cyclically Adjusted PS Ratio: 1.04 (99% below median its 10-year median of 81.84)
GF Value™: kr0.51 vs. price of kr7.66 (1402% above fair value)
Industry Position: 37.7% below the Software median (#582 of 1591)
No single metric tells the full story. See the OSL:IDEX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IDEX Biometrics ASA develops and manufactures fingerprint biometric cards for access control, digital identity, and payment. Its products use fingerprint biometrics for user authentication and are designed for physical and digital access applications. The company serves banks, enterprises, and public sector organizations through direct sales and channel partners.
32GF Score
Get the complete analysis for OSL:IDEX
Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSL:IDEX has been successfully added to your 
